Device manufacturer, as written on reports

Abbott Vascular-Cardiac Therapies: medical device reports filed with FDA

6,218 reports name it as the manufacturer of the device involved, 2007–2010.

Read first · FDA's statement on these data

Adverse event reports submitted to FDA do not undergo extensive validation or verification. Therefore, a causal relationship cannot be established between product and reactions listed in a report. While a suspected relationship may exist, it is not medically validated and should not be the sole source of information for clinical decision making or other assumptions about the safety or efficacy of a product. Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product. openFDA, FDA

FDA adds: "Although MDRs are a valuable source of information, this passive surveillance system has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data. In addition, the incidence or prevalence of an event cannot be determined from this reporting system alone due to potential under-reporting of events and lack of information about frequency of device use." And: "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices."

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated.

Not medical advice. This site counts what was reported to FDA. Questions about a medicine or device belong with a pharmacist or clinician.

6,218
reports naming it as manufacturer: 0% of all MAUDE reports; 0
reports, 12 months to August 2026: 0 in the 12 months before; 36.6%
classified as malfunction: 62.3% across all reports; 7.6%
classified as death, as reported: 0.9% across all reports

6,218 medical device reports received by FDA give Abbott Vascular-Cardiac Therapies as the manufacturer of the device involved, 0% of the MAUDE database, from June 2007 to December 2010. Manufacturer names are as written on the report; subsidiaries and spelling variants may appear as separate names.

0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (55.8%), malfunction (36.6%) and death (7.6%). Manufacturers are required to report events they learn of, so a large manufacturer with many products in use files many reports. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Brands named most often

Brand	Device type	Reports	Latest 12 months	Classified as death
Xience V Everolimus Eluting Coronary Stent System	Coronary drug-eluting stent	2,063	9	11.6%
Promus Everolimus Eluting Coronary Stent System	Coronary drug-eluting stent	794	0	11.3%
Multi-Link Rx Vision Coronary Stent System	Stent, coronary	683	0	4.2%
Voyager Rx Coronary Dilatation Catheter	Catheters, transluminal coronary angioplasty, percutaneous	476	0	0.7%
Jostent Graftmaster	Stent, coronary	348	0	23.5%
Multi-Link Mini Vision Rx Coronary Stent System	Stent, coronary	296	0	4.7%
Voyager Nc Coronary Dilatation Catheter	Catheters, transluminal coronary angioplasty, percutaneous	256	0	0.5%
Hi-Torque Balance Middleweight Universal Guide Wire	Wire, guide, catheter	95	0	1.3%
Multi-Link Rx Pixel Coronary Stent System	Stent, coronary	80	0	4.3%
Multi-Link Rx Zeta Coronary Stent System	Stent, coronary	64	0	6.6%
Powersail Coronary Dilatation Catheter	Catheters, transluminal coronary angioplasty, percutaneous	57	0	1.1%
Acs Hi-Torque Balance Middleweight Guide Wire	Wire, guide, catheter	52	0	3.2%
Acs Multi-Link Rx Ultra Coronary Stent System	Stent, coronary	39	0	3.8%
Multi-Link 8	Stent, coronary	34	1	1.6%
XIENCE Everolimus Eluting Coronary Stent System	Coronary drug-eluting stent	23	29	32.7%
Acs Hi-Torque Balance Middleweight Guide Wire With Hydrocoat Hydrophilic Coating	Wire, guide, catheter	22	0	1.3%
Hi-Torque Pilot Guide Wire	Wire, guide, catheter	22	0	4.3%
Trek Coronary Dilatation Catheter	Catheters, transluminal coronary angioplasty, percutaneous	11	3	1.1%
Mini Trek Coronary Dilatation Catheter	Catheters, transluminal coronary angioplasty, percutaneous	8	0	0.5%

Brands with a page on this site, ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Device types

Product code	Device type	Reports	Share
NIQ	Coronary drug-eluting stent	2,977	47.9%
MAF	Stent, coronary	2,028	32.6%
LOX	Catheters, transluminal coronary angioplasty, percutaneous	589	9.5%
DQX	Wire, guide, catheter	508	8.2%
MCX	Catheter, coronary, atherectomy	74	1.2%
DRA	Catheter, steerable	11	0.2%
MAV	Syringe, balloon inflation	11	0.2%
DQO	Catheter, intravascular, diagnostic	4	0.1%
LIT	Catheter, angioplasty, peripheral, transluminal	3	0%
DQY	Catheter, percutaneous	2	0%

Reports by month, five years

FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type

Death7.6%471

Injury55.8%3,468

Malfunction36.6%2,274

Other0%2

Not given0%3

Grey bar: all 26,136,888 MAUDE reports. Event type is the filer's classification and is not verified by FDA.

Questions about Abbott Vascular-Cardiac Therapies reports

How many FDA device reports name Abbott Vascular-Cardiac Therapies as manufacturer?

6,218 reports through August 2026, 0 of them in the latest 12 months.

Which of its brands appear most often?

Xience V Everolimus Eluting Coronary Stent System (2,063), Promus Everolimus Eluting Coronary Stent System (794), Multi-Link Rx Vision Coronary Stent System (683), Voyager Rx Coronary Dilatation Catheter (476) and Jostent Graftmaster (348).

Which device types does it report on?

coronary drug-eluting stent (47.9%), stent, coronary (32.6%), catheters, transluminal coronary angioplasty, percutaneous (9.5%) and wire, guide, catheter (8.2%).

Does a high count say something about the manufacturer?

Not by itself. Manufacturers must file a report for every event they become aware of, so report volume follows the number of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. Manufacturer names are pooled after company suffixes (Inc., LLC, GmbH and similar) are dropped; names that read as a person rather than an organisation are never published. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.